AbbVie strengthening its manufacturing capabilities, will employ 500 people
AbbVie expanded its Singapore manufacturing facility on 25th Jan, strengthening its manufacturing capabilities. With a new $223 million (S$301 million) investment, A state-of-the-art facility for manufacturing biologics and small molecules, AbbVie's Singapore plant is located in Singapore's Tuas Biomedical Park. Const…
